Pricing Log in Create free account

Decoy Therapeutics Inc (DCOY) vs KALA BIO, Inc. (KALA)

Decoy Therapeutics Inc and KALA BIO, Inc. are both Biotechnology companies. KALA BIO, Inc. is the larger, with a market value of $3.0M against $2.7M — 1.1× the size. KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −60.5%. KALA BIO, Inc. has the higher net margin (0.00% vs −698.8%) and the lower return on invested capital (−722.7% vs 0.00%). Across the 16 metrics below, KALA BIO, Inc. leads on 9 and Decoy Therapeutics Inc on 7.

Valuation

Metric DCOY KALA Biotechnology median
P/E n/m n/m 10.60
P/S 0.29 0.52 9.40
P/B 0.14 0.33 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.49 n/m 0.66
EV/Sales (3.49) 8.04 9.02
Earnings yield (5,122.62%) (31,890.31%) (32.88%)
Free cash flow yield (1,736.93%) (667.16%) (23.13%)

Profitability

Metric DCOY KALA Biotechnology median
Gross margin 10.57% 0.00% 68.51%
Operating margin (706.88%) 0.00% 0.00%
Net margin (698.79%) 0.00% 0.00%
Free cash flow margin (432.43%) 0.00% 0.00%
Return on equity (827.77%) (345.32%) (51.96%)
Return on assets (278.04%) (43.23%) (46.06%)
Return on invested capital 0.00% (722.69%) 0.00%

Growth

Metric DCOY KALA Biotechnology median
Revenue growth (TTM) (60.49%) (50.54%) 6.76%
EPS growth (last fiscal year) 87.62% 67.39% 29.88%
Revenue growth, 5-year CAGR 12.73% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCOY KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.83 6.88 4.97
Net debt to EBITDA 0.85 0.19 1.01

Dividend

Metric DCOY KALA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DCOY KALA Biotechnology median
Market cap 2.67m 2.95m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack